Astera Labs, Inc. (ALAB) FY2026 Q2 Balance Sheet

Astera Labs, Inc. (ALAB) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

1,931,501,000 US dollars

Current assets

1,651,895,000 US dollars

Non-current assets

279,606,000 US dollars

Liabilities

205,797,000 US dollars

Current liabilities

164,307,000 US dollars

Non-current liabilities

41,490,000 US dollars

Equity

1,725,704,000 US dollars

Marketable securities

1,141,505,000 US dollars

Accounts receivable, net

192,469,000 US dollars

Inventory

113,781,000 US dollars

Cash and cash equivalents

111,453,000 US dollars

Prepaid expenses and other current assets

92,687,000 US dollars

Property and equipment, net

119,284,000 US dollars

Goodwill

91,557,000 US dollars

Other assets

68,765,000 US dollars

Accrued expenses and other current liabilities

110,377,000 US dollars

Accounts payable

53,930,000 US dollars

Other liabilities

41,490,000 US dollars

Additional paid-in capital

1,485,320,000 US dollars

Retained earnings

243,736,000 US dollars

Common stock, $0.0001 par value; 1,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 173,485 and 170,186 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively

17,000 US dollars

Accumulated other comprehensive (loss) income

negative 3,369,000 US dollars

Gross equity (calculated)

1,729,073,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.